Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-06-21

Clinical Trial Update: Efficacy and Safety of Dorner Tablets and Aspirin for Prevention of Arteriosclerosis Progress in Type 2 Diabetes Mellitus Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy and safety of Dorner Tablets in combination with aspirin for prevention of arteriosclerosis progression in patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)
  • Dorner Tablets

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: TERMINATED